Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL27941813 | 0.89 | BLM (0.53) | — | |
| Sulfamate SCHEMBL26965441 | 0.88 | — | — | |
| Acetamide SCHEMBL27622549 | 0.88 | BLM (0.61) | — | |
| Acetamide SCHEMBL5320059 | 0.88 | — | — | |
| Acetamide SCHEMBL28019241 | 0.88 | BLM (0.61) | — | |
| Acetamide SCHEMBL27964490 | 0.85 | BLM (0.57) | — | |
| Dimethyl Sulfone SCHEMBL21635409 | 0.83 | — | — | |
| Sulfuric Acid SCHEMBL677554 | 0.82 | — | — | |
| Sulfuric Acid SCHEMBL3902876 | 0.82 | CA5A (0.60) | — | |
| Sulfuric Acid SCHEMBL379310 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117285514-A | Solid forms of HIV capsid inhibitor | 吉利德科学公司 | 2023-12-26 | — | — | CN | claimed |
| CN-115737909-A | Preparation method and application of nanofiber material taking polycaprolactone as matrix | 慧迈材料科技(广东)有限公司 | 2023-03-07 | — | — | CN | claimed |
| CN-119522917-A | Spring thunder acetamide composition and application thereof | 陕西麦可罗生物科技有限公司 | 2025-02-28 | — | — | CN | disclosed |
| US-20240238328-A1 | Sulfated Glycosaminoglycan Biomaterials as Proteoglycan Mimics | GLYCOLOGIX INC (US) | 2024-07-18 | — | — | US | disclosed |
| CN-117694347-A | Spring thunder acetamide composition and application thereof | 陕西麦可罗生物科技有限公司 | 2024-03-15 | — | — | CN | disclosed |
| US-11911411-B2 | Sulfated glycosaminoglycan biomaterials as proteoglycan mimics | GLYCOLOGIX, INC. (US) | 2024-02-27 | — | — | US | disclosed |
| CN-117285514-A | Solid forms of HIV capsid inhibitor | 吉利德科学公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-116831126-B | Spring thunder acetamide composition and application thereof | 中国远大集团有限责任公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-116831126-A | Spring thunder acetamide composition and application thereof | 中国远大集团有限责任公司 | 2023-10-03 | — | — | CN | disclosed |
| WO-2023086320-A1 | FORMS AND COMPOSITIONS OF INHIBITORS OF JAK2 | AJAX THERAPEUTICS, INC. (US) | 2023-05-19 | — | — | WO | disclosed |
| CN-115697352-A | Sulfated glycosaminoglycan biomaterials as proteoglycan mimetics | 格莱克罗吉克斯公司 | 2023-02-03 | — | — | CN | disclosed |
| EP-4121064-A1 | SULFATED GLYCOSAMINOGLYCAN BIOMATERIALS AS PROTEOGLYCAN MIMICS | Glycologix, Inc. (US) | 2023-01-25 | — | — | EP | disclosed |
| WO-2021188882-A1 | SULFATED GLYCOSAMINOGLYCAN BIOMATERIALS AS PROTEOGLYCAN MIMICS | GLYCOLOGIX, LLC (US) | 2021-09-23 | — | — | WO | disclosed |
| US-20210290657-A1 | Sulfated Glycosaminoglycan Biomaterials as Proteoglycan Mimics | GLYCOLOGIX, LLC | 2021-09-23 | — | — | US | disclosed |
| WO-2015162584-A1 | CRYSTALLINE FORMS OF THE SULFATE SALT OF N-[5-(3-IMIDAZOL-1-YL-4-METHANESULFONYL-PHENYL)-4-METHYL-THIAZOL-2-YL]-ACETAMIDE | NOVARTIS AG (CH) | 2015-10-29 | — | — | WO | disclosed |
| CN-102365017-A | Treatment of acute exacerbations of asthma and reduction of likelihood of hospitalization of asthmatic patients | MEDICINOVA INC | 2012-02-29 | — | — | CN | disclosed |
| CN-1213722-C | Couplers for oxidative hair dyeing | P & G CLAIROL INC (US) | 2005-08-10 | — | — | CN | disclosed |
| CN-1474680-A | Novel couplers for oxidative hair dyeing | P&G克莱罗尔公司 | 2004-02-11 | — | — | CN | disclosed |
| US-4361516-A | N-Monosubstituted indoanilines | SOCIETE ANONYME DITE: L'OREAL (FR) | 1982-11-30 | — | — | US | disclosed |